The incidence of dry cough was significantly lower in patients treated with telmisartan than in those given angiotensin converting enzyme inhibitors in clinical trials directly comparing the two antihypertensive treatments.
Kliiniliste uuringute alusel esines telmisartaaniga ravitud patsientidel kuiva köha tunduvalt vähem kui AKE- inhibiitoritega ravitud haigetel.